Dulap Mov pustietate gene asxl1 lungime angrena Doctor
Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases | Journal of Hematology & Oncology | Full Text
ASXL1 mutations are associated with distinct epigenomic alterations that lead to sensitivity to venetoclax and azacytidine | Blood Cancer Journal
Epigenetic targeted therapy of stabilized BAP1 in ASXL1 gain-of-function mutated leukemia | Nature Cancer
Epigenetic regulation by ASXL1 in myeloid malignancies | International Journal of Hematology
ASXL1/2 mutations and myeloid malignancies | Journal of Hematology & Oncology | Full Text
Oncogenic truncations of ASXL1 enhance a motif for BRD4 ET-domain binding | bioRxiv
Aberrant histone modifications induced by mutant ASXL1 in myeloid neoplasms | International Journal of Hematology
ASXL1 mutation correction by CRISPR/Cas9 restores gene function in leukemia cells and increases survival in mouse xenografts. - Abstract - Europe PMC
ASXL1 (additional sex combs like 1 (Drosophila))
ASXL1/2 mutations and myeloid malignancies | Journal of Hematology & Oncology | Full Text
Generation of the Asxl1 G643WfsX12 knock-in mice. a Schematic... | Download Scientific Diagram
Asxl1 C-terminal mutation perturbs neutrophil differentiation in zebrafish | Leukemia
ASXL1 promotes adrenocortical carcinoma and is associated with chemoresistance to EDP regimen - Figure f1 | Aging
CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia - ScienceDirect
Role of ASXL1 in hematopoiesis and myeloid diseases - ScienceDirect
Hypothetical model for the role of ASXL1 in cell cycle progression... | Download Scientific Diagram
ASXL1 | JCGA
Asxl1 C-terminal mutation perturbs neutrophil differentiation in zebrafish | Leukemia
Dynamic ASXL1 Exon Skipping and Alternative Circular Splicing in Single Human Cells | PLOS ONE
Epigenetics and mutations in chronic myeloproliferative neoplasms | Haematologica
Figure 1 from Role of ASXL1 and TP53 mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changes | Semantic Scholar